These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1
28 results:

  • 1. PTEN depletion reduces H3K27me3 levels to promote epithelial-to-mesenchymal transition in epithelial colorectal cancer cells.
    Ghobashi AH; Kimani JW; Ladaika CA; O'Hagan HM
    PLoS One; 2024; 19(11):e0313769. PubMed ID: 39561122
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Knocking down of lncRNA SBF2-AS1 inhibits proliferation, invasion and induces apoptosis of colorectal cancer through regulating PTEN.
    Cai Y; Yan H; Wang F; Xie L
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):201-205. PubMed ID: 38279439
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-canonical transcriptional regulation of INHAT subunit SET/TAF-Iβ by EZH2.
    Hwang IJ; Park J; Seo SB
    Biochem Biophys Res Commun; 2022 Dec; 635():136-143. PubMed ID: 36274363
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.
    Naert T; Tulkens D; Van Nieuwenhuysen T; Przybyl J; Demuynck S; van de Rijn M; Al-Jazrawe M; Alman BA; Coucke PJ; De Leeneer K; Vanhove C; Savvides SN; Creytens D; Vleminckx K
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34789568
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease.
    Zhou R; Qiu P; Wang H; Yang H; Yang X; Ye M; Wang F; Zhao Q
    Aging (Albany NY); 2021 Feb; 13(3):4634-4646. PubMed ID: 33535181
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA CRNDE facilitates epigenetic suppression of CELF2 and LATS2 to promote proliferation, migration and chemoresistance in hepatocellular carcinoma.
    Xie SC; Zhang JQ; Jiang XL; Hua YY; Xie SW; Qin YA; Yang YJ
    Cell Death Dis; 2020 Aug; 11(8):676. PubMed ID: 32826865
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in colorectal cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]    [Full Text] [Related]  

  • 8. DNA methylation-regulated and tumor-suppressive roles of miR-487b in colorectal cancer via targeting MYC, suz12, and KRAS.
    Chen X; Lin ZF; Xi WJ; Wang W; Zhang D; Yang F; Li YF; Huo Y; Zhang TZ; Jiang YH; Qin WW; Yang AG; Wang T
    Cancer Med; 2019 Apr; 8(4):1694-1709. PubMed ID: 30791232
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. STRAP Promotes Stemness of Human colorectal cancer via Epigenetic Regulation of the NOTCH Pathway.
    Jin L; Vu T; Yuan G; Datta PK
    Cancer Res; 2017 Oct; 77(20):5464-5478. PubMed ID: 28827371
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. tRF/miR-1280 Suppresses Stem Cell-like Cells and Metastasis in colorectal cancer.
    Huang B; Yang H; Cheng X; Wang D; Fu S; Shen W; Zhang Q; Zhang L; Xue Z; Li Y; Da Y; Yang Q; Li Z; Liu L; Qiao L; Kong Y; Yao Z; Zhao P; Li M; Zhang R
    Cancer Res; 2017 Jun; 77(12):3194-3206. PubMed ID: 28446464
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor.
    Yang ZZ; Li L; Xu MC; Ju HX; Hao M; Gu JK; Jim Wang ZJ; Jiang HD; Yu LS; Zeng S
    Oncotarget; 2017 Apr; 8(17):29138-29150. PubMed ID: 28418861
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon cancer.
    Nagarsheth N; Peng D; Kryczek I; Wu K; Li W; Zhao E; Zhao L; Wei S; Frankel T; Vatan L; Szeliga W; Dou Y; Owens S; Marquez V; Tao K; Huang E; Wang G; Zou W
    Cancer Res; 2016 Jan; 76(2):275-82. PubMed ID: 26567139
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment.
    Yan H; Tang G; Wang H; Hao L; He T; Sun X; Ting AH; Deng A; Sun S
    Oncogene; 2016 Jul; 35(30):3995-4008. PubMed ID: 26549033
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor suz12 in colon cancer cells.
    Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
    Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
    Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Generation of an anti-EpCAM antibody and epigenetic regulation of EpCAM in colorectal cancer.
    Liao MY; Kuo MY; Lu TY; Wang YP; Wu HC
    Int J Oncol; 2015 Apr; 46(4):1788-800. PubMed ID: 25652097
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression and clinicopathological significance of EED, suz12 and EZH2 mRNA in colorectal cancer.
    Liu YL; Gao X; Jiang Y; Zhang G; Sun ZC; Cui BB; Yang YM
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):661-9. PubMed ID: 25326896
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic value of polycomb proteins EZH2, BMI1 and suz12 and histone modification H3K27me3 in colorectal cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
    PLoS One; 2014; 9(9):e108265. PubMed ID: 25243792
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.